Indication
Bloodstream Infections (BSI)
1 clinical trial
2 products
Clinical trial
A Single Arm, Open-label Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Paediatric Subjects 3 Months to <18 Years of Age With Suspected or Confirmed Aerobic Gram-negative Bacterial InfectionsStatus: Completed, Estimated PCD: 2023-02-06
Product
Standard of CareProduct
Cefiderocol